Literature DB >> 1338431

Effect of a centrally-acting muscle relaxant, eperisone hydrochloride, on muscle sympathetic nerve activity in humans.

S Iwase1, T Mano, M Saito, G Ishida.   

Abstract

The sympatho-modulating effects of eperisone hydrochloride, a centrally acting muscle relaxant, on microneurographically recorded muscle sympathetic nerve activity (MSA) were analyzed in human volunteers. A single dose of 300 mg of eperisone was orally administered to 19 healthy subjects aged between 19 and 27, and effects on 1) spontaneous MSA in 30 degrees head-up tilted position, 2) resting MSA and responsiveness to standing, 3) exercise-induced enhancement of MSA were observed. Eperisone has a sympatho-suppressive action in resting skeletal muscles, but has no effect on MSA in actively contracting muscles, e.g. standing, hand-gripping. The sympatho-suppressive effect of eperisone may be related to the drug-induced increase of blood low in the resting skeletal muscles; also it may be one more mechanism through which the drug can exert its muscle relaxant action.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1338431

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  4 in total

1.  Oral muscle relaxant may induce immediate allergic reactions.

Authors:  Gyu-Young Hur; Eui Kyung Hwang; Jae-Young Moon; Young-Min Ye; Jae-Jeong Shim; Hae-Sim Park; Kyung-Ho Kang
Journal:  Yonsei Med J       Date:  2012-07-01       Impact factor: 2.759

2.  Human pharmacokinetics of the muscle relaxant, eperisone hydrochloride by liquid chromatography-electrospray tandem mass spectrometry.

Authors:  Barbara Melilli; Cateno Piazza; Daniela Cristina Vitale; Maria Rosa Marano; Andrea Pecori; Paolo Mattana; Valentina Li Volsi; Carmelo Iuculano; Francesco Cardì; Filippo Drago
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-03-30       Impact factor: 2.441

3.  Therapeutic effects of eperisone on pulmonary fibrosis via preferential suppression of fibroblast activity.

Authors:  Ken-Ichiro Tanaka; Mikako Shimoda; Toshifumi Sugizaki; Maki Ikeda; Ayaka Takafuji; Masahiro Kawahara; Naoki Yamakawa; Tohru Mizushima
Journal:  Cell Death Discov       Date:  2022-02-08

4.  Randomized Controlled Trial of Etodolac versus Combination of Etodolac and Eperisone in Patients of Knee Osteoarthritis.

Authors:  Navjot Kaur; Harinder Singh; Avinash Chander Gupta
Journal:  Pain Res Treat       Date:  2013-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.